Analgesic effects of low-dose ropivacaine for interscalene brachial plexus block for outpatient shoulder surgery - A dose-finding study

Regional Anesthesia and Pain Medicine

Volumn 26, Issue 5, 2001, Pages 439-443

  Krone, Susanne C ^a   Chan, Vincent W S ^a   Regan, Joan ^a   Peng, Philip ^a   Poate, Eileen M ^a   McCartney, Colin ^a   Miniaci, Anthony ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Interscalene brachial plexus block, Local anesthetics; Outpatient, Shoulder arthroscopy, Analgesia; Postoperative; Ropivacaine, Surgery

Indexed keywords

ANALGESIC AGENT; FENTANYL; GLYCOPYRRONIUM BROMIDE; ISOFLURANE; KETOROLAC; LIDOCAINE; LOCAL ANESTHETIC AGENT; MIDAZOLAM; MORPHINE; NEOSTIGMINE; NITROUS OXIDE; OXYGEN; PARACETAMOL; PROPOFOL; ROCURONIUM; ROPIVACAINE;

AMBULATORY SURGERY; ANALGESIA; ARTHROSCOPY; ARTICLE; BRACHIAL PLEXUS ANESTHESIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG USE; FEMALE; GENERAL ANESTHESIA; HOARSENESS; HORNER SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NERVE BLOCK; NAUSEA; PAIN ASSESSMENT; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY NERVE; SHOULDER;

EID: 0034829151     PISSN: 10987339     EISSN: None     Source Type: Journal    
DOI: 10.1053/rapm.2001.25914     Document Type: Article

References (9)

1. Acute toxicity of ropivacaine compared with that of bupivacaine
2. A comparison of 0.5% bupivacaine, 0.5% ropivacaine, and 0.75% ropivacaine for interscalene brachial plexus block
3. Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor: Implications for therapeutic indexes
4. Analgesic effect of interscalene block using low-dose bupivacaine for outpatient arthroscopic shoulder surgery
5. Interscalene brachial plexus block
6. The post-anesthesia recovery score revisited
7. Are discharge criteria changing?
8. A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block
9. Brachial plexus block with a new local anaesthetic: 0.5 per cent ropivacaine